期刊文献+

晚期结直肠癌中医治疗预后因素分析 被引量:7

Analysis of prognostic factors in TCM treating patients with advanced colorectal cancer
下载PDF
导出
摘要 目的筛选晚期结直肠癌中医治疗的预后因素。方法采用回顾性连续病例研究方法,将影响晚期结直肠癌预后的多个因素进行单因素和多因素Cox回归分析,建立晚期结直肠癌中医治疗生存预测模型,分析中医治疗效应指标的预后作用。结果 89例晚期结直肠癌患者纳入研究,全组中位生存期为15.56个月。单因素分析表明瘤体大小、Karnofsky评分、体质量、主症及疼痛变化5个因素与预后相关,多因素回归分析表明瘤体大小、Karnofsky评分、体质量及主症变化4项为独立预后因素。结论瘤体大小、Karnofsky评分、体质量及主症变化是中医治疗晚期结直肠癌的重要预后指标。 【Objective】 To select the prognostic factors in TCM treating patients with advanced colorectal cancer.【Methods】 Using a retrospective case study method,the univariate and multivariate Cox regression analysis were used to analyze the clinical factors that affect the prognosis of advanced colorectal cancer,then the survival prediction model was built up,and the prognostic value of TCM effect indicators were analyzed.【Results】89 patients with advanced colorectal cancer were included in the study.The median survival time was 15.56 months.With univariate analysis,changes in tumor size,KPS,weight,main symptoms and pain were found to be significant factors influencing the prognosis.Changes in tumor size,KPS,weight and main symptoms were proved independently to be the risk factors influencing prognosis by multi-factorial analysis.【Conclusion】Changes in tumor size,KPS,weight and main symptoms were important prognostic indicators for TCM treating patients with advanced colorectal cancer.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2013年第14期108-112,共5页 China Journal of Modern Medicine
关键词 晚期结直肠癌 中医治疗 预后 advanced colorectal cancer TCM treatment prognosis
  • 相关文献

参考文献21

二级参考文献115

  • 1杨玲,李连弟,陈育德,D.M.Parkin.中国2000年及2005年恶性肿瘤发病死亡的估计与预测[J].中国卫生统计,2005,22(4):218-221. 被引量:336
  • 2吴晓华,张莘,周文阔,易喜贤,吴涛,徐惠绵.p16和PTEN抑癌基因蛋白在结直肠腺癌组织中的表达及临床意义[J].中国肿瘤临床与康复,2006,13(1):11-13. 被引量:2
  • 3韩洪秋,刘彤,赵丽中,戚峰,王鹏志.国际新的TNM分期对分析结直肠癌预后的临床意义[J].中华医学杂志,2006,86(12):819-821. 被引量:13
  • 4Sobin LH, Fleming ID. TNM classification of Malignant tumors, Fifth edition(1997). Union international control cancer and the American Joint Committee on cancer[J].Cancer, 1997,80:1803.
  • 5Gospodarowicz MK, Miller D, Groome PA, et al. The process for continuous improvement of the TNM classification[J].Cancer, 2004,100: 1.
  • 6Singletary SE ,Greene FI,Sobin LH. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual[J]. Cancer,2003,98 : 2740.
  • 7Greene FL,Stewart AK,Norton HJ. A new TNM staging stratey for node-positive(stage Ⅲ) Colon cancer, an analysis of 50 042 patients[J]. Ann Surg, 2002,236:416.
  • 8Edge SB,Sobin LH,Page DL,et al. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging[J]. J Natl Cancer Inst, 2005,97:463.
  • 9Ogino S, Cantor M, Kawasaki T, et al. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies[J]. Gut, 2006, 55(7):1000-1006.
  • 10Ogino S, Kawasaki T, Kirkner G J, et al. Down-regulation of p21 (CDKN1A/ CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer[J]. Patbol, 2006, 210(2):147- 154.

共引文献115

同被引文献125

  • 1张思维,雷正龙,李光琳,邹小农,陈万青,赵平.中国肿瘤登记地区2005年发病死亡资料分析[J].中国肿瘤,2009,18(12):973-979. 被引量:32
  • 2直肠癌规范化诊疗指南(试行)[J].中国医学前沿杂志(电子版),2013,5(7):56-61. 被引量:38
  • 3张青,赵文硕,于洁,王笑民.益气活血中药联合化疗治疗晚期大肠癌的临床研究[J].中国中医药信息杂志,2006,13(10):17-18. 被引量:25
  • 4杨宇飞,许云,吴煜,王兰萍,李贞,张灵智,朱尧武,郭中宁,郭全,阎小平.祛邪胶囊减少大肠癌术后复发转移的临床随机双盲对照研究[J].中国中西医结合杂志,2007,27(10):879-882. 被引量:30
  • 5Zauber AG, Winawer SJ, OBrien MJ, et al. Colonoscopic polypec- tomy and long-term prevention of colorectal-cancer deaths [ J ]. N Engl J Med,2012,366(8) :687-696.
  • 6Javle M, Hsueh CT. Updates in Gastrointestinal Oncology-insights from the 2008 44th annual meeting of the American Society of Clinical Oncology [ J ]. J Hematol Oncol, 2009, 2 ( 1 ) : 1-13.
  • 7Heresbach D, Barrioz T, Lapalus MG, et al. Miss rate for colorectal neoplastic polyps:a prospective multicenter study of back-to-back video colonoscopies [ J]. Endoscopy,2008,40 (4) :284-290.
  • 8Van RJC, Reitsma JB, Stoker J, et al. Polyp miss rate determined by tandem colonoscopy: a systematic review[ J]. Am J Gastroen- terol, 2006, 101 ( 2 ) : 343-350.
  • 9Bertelson NL, Kalkbrenner KA, Merchea A, et al. Colectomy for en- doscopically unresectable polyps:how often is it cancer [ J ]. Dis Colon Rectum, 2012, 55(11) :1111-1116.
  • 10Bressler B, Paszat LF, Ghen Z, et al. Rates of new or missed color- ectal cancers after colonoscopy and their risk factors : a popula- tion-based analysis[ J]. Gastroenterology,2007,132 ( 1 ) :96-102.

引证文献7

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部